RemiStart®... Patient Rebate Program for REMICADE®


Eligible patients pay $5 per infusion*

*$20,000 maximum program benefit per calendar year.

To learn more about eligibility requirements, click here >>

 

Before the calendar year ends, you will receive information and eligibility requirements for continued benefit in the program.

Click here to complete and submit RemiStart® form >>

Janssen Biotech, Inc. is not liable for unintended or unauthorized use of the RemiStart® Patient Rebate Program for REMICADE® MasterCard® if it is lost or stolen. This card is issued by MetaBank®, Member FDIC, pursuant to license by MasterCard International Incorporated. MasterCard is a registered trademark of MasterCard International Incorporated. RemiStart® is not a MetaBank product and is not endorsed by them.